FDA NDC Directory · JSON-LD · Markdown

Cinryze

NDC 42227-081 · PLASMA DERIVATIVE · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameHUMAN C1-ESTERASE INHIBITOR
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA125267
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsHUMAN C1-ESTERASE INHIBITOR (500 [iU]/5mL)
Marketing started20081201
Package count1

External sources

Source: openFDA. Public-domain (CC0).